Skip to Main content Skip to Navigation
Journal articles

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Document type :
Journal articles
Complete list of metadatas

https://hal.univ-lorraine.fr/hal-03144487
Contributor : Djésia Arnone <>
Submitted on : Wednesday, February 17, 2021 - 4:24:47 PM
Last modification on : Wednesday, February 17, 2021 - 4:24:49 PM

Links full text

Identifiers

Collections

Citation

Bruce Sands, Laurent Peyrin-Biroulet, Edward Loftus, Silvio Danese, Jean-Frédéric Colombel, et al.. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. New England Journal of Medicine, Massachusetts Medical Society, 2019, 381 (13), pp.1215-1226. ⟨10.1056/NEJMoa1905725⟩. ⟨hal-03144487⟩

Share

Metrics

Record views

6